In 2026, the cannabis industry finds itself in an unfamiliar position. Its first-ever annual sales decline is in the rearview; federal cannabis rescheduling is underway; and a sweeping hemp-derived THC ban that is certain to shake up the market looms large. On top of that, changing cannabis consumer behavior is driving retailers to reevaluate strategies and SOPs to keep new customers coming in and previous customers coming back in this new landscape.
In this article, we’re diving deeper into the 2026 cannabis industry statistics data to analyze the biggest cannabis market trends dispensary owners and operators need to understand.
Key Takeaways
- Pre-rolls officially overtook flower as the fastest-growing category, adding $80 million in sales in 2025 while flower declined $30 million (Headset)
- Cannabis beverages grew 15% YoY in Q1 2025, the fastest percentage growth of any product category, with Michigan up 112% and Ohio up 79% (BDSA)
- 42% of edible consumers now prefer 10mg or less, signaling a shift toward functional, low-dose consumption rather than high-THC products (BDSA)
- The hemp-derived THC ban takes effect November 12, 2026, removing nearly every intoxicating hemp product from retail — a meaningful competitive shift for licensed dispensaries
- 4/20 per-store revenue has trended well below its 2019 peak as new dispensaries split the same demand; total industry 420 spending keeps growing, but the per-store windfall is a thing of the past (Cova)
1. Cannabis Product Category Trends
Pre-rolls officially overtook flower as the fastest-growing product category in 2025, while beverages lead all categories in percentage growth. The industry is shifting toward convenience and controlled dosing, and operators who haven't adjusted their product mix are already behind.
Pre-Roll Dominance
The pre-roll category has grown 110% from 2021 to 2025, from $1.7 billion to $3.6 billion, according to Headset and Custom Cones USA. In 2025, pre-rolls added $80 million in sales while flower declined $30 million — a category rotation that has been building for years and shows no signs of slowing.
Key data points:
- 394 million pre-roll units sold in 2024 (Custom Cones USA)
- 15.9% of total cannabis sales in Q1 2026 went to pre-rolls (Headset)
- Infused pre-rolls — containing concentrates, hash, or distillate in addition to flower — hold 43% market share within the category (Custom Cones USA)
- Multi-packs grew from 27.7% of the market in 2018 to nearly 50% today, driven by value-conscious consumers (Custom Cones USA)
- Millennials account for approximately 45% of pre-roll spending (Custom Cones USA)
The infused pre-roll is the most important subcategory to understand. At 43% of unit share and nearly half of total pre-roll revenue ($1.68 billion), infused products are no longer a premium niche; they're the growth engine of the category. Operators stocking only standard joints are leaving money on the table.
What this means for dispensaries: Expand pre-roll SKUs, with priority on infused options and multi-pack formats. These products serve the convenience buyer and the value-conscious consumer simultaneously. If your current POS makes it difficult to track pre-roll inventory at the variant level (standard vs. infused, single vs. multi-pack), that's a solvable problem. Cova's inventory management platform gives operators SKU-level visibility across all product formats in real time.
Cannabis Beverages: Small Share, Fastest Growth
Cannabis beverages still represent less than 1% of total dollar sales, but they are growing faster than any other category. According to BDSA's Q1 2025 data:
- $54.6 million in beverage sales in Q1 2025, up 15% year-over-year
- Michigan: +112% YoY beverage growth
- Ohio: +79% YoY beverage growth
The growth is concentrated in newer markets where consumers are encountering beverages for the first time, which suggests the trajectory will steepen as adult-use markets mature. In established markets like California and Colorado, beverages are already normalized enough to be a standard fixture of a well-merchandised store.
The Low-Dose Trend
The days of competing on potency alone are winding down. According to BDSA, 42% of edible consumers now prefer doses of 10mg or less, with the most popular dosage range sitting at 2.5 to 5mg. This reveals that consumers are gravitating toward functional, predictable effects over maximum THC percentages, particularly in the wellness-oriented segments driving growth among older adults and first-time users.
What this means for dispensaries: Low-dose and functional products deserve dedicated shelf space and budtender attention. Operators who train staff to confidently recommend dosing options and who carry a deep selection in the 2.5-10mg range are better positioned to serve the fastest-growing consumer demographics. For a full breakdown of which products are trending by season, see Cannabis Product Trends 2026: Seasonal Sales Trends by Category and Most Popular Cannabis Products Every Dispensary Should Stock.
2. Consumer Behavior and Demographic Shifts
The cannabis consumer base is diversifying rapidly. Women represent a growing share of buyers, older adults are the highest per-visit spenders, and the majority of consumers now say they choose cannabis over alcohol when given the choice. Meanwhile, 4/20 spending data from Cova's platform reveals a maturing market where event-driven purchasing is giving way to routine buying behavior.
The Changing Face of the Cannabis Consumer
Women now represent an estimated 42% of cannabis consumers, up from approximately 35% in 2020. According to NIDA, women aged 19-30 surpassed men in cannabis consumption rates for the first time in 2023 — a shift that's showing up in product preferences and purchase patterns.
Women tend to purchase an average of 3.0 items per visit compared to 2.7 for men, and they index higher toward edibles, topicals, tinctures, and beverages. These are also among the fastest-growing categories industrywide, which is not a coincidence.
Generational spending patterns reveal equally important dynamics:
- Gen Z is the fastest-growing cohort but has the lowest average order value
- Boomers visit less frequently but spend more per trip, with larger cart sizes
- Millennials represent the largest share of pre-roll spending at approximately 45% (Custom Cones USA)
The takeaway for operators is straightforward: don't optimize for one demographic. Older consumers drive per-visit revenue. Younger consumers drive frequency. A well-built product mix and staff training program should serve both.
Cannabis vs. Alcohol
The cannabis-versus-alcohol dynamic has crossed a meaningful threshold. According to New Frontier Data, 62% of consumers choose cannabis over alcohol when given the choice, and 57% have replaced some of their drinking with cannabis use. Research published in PubMed found that daily cannabis users now outnumber daily alcohol drinkers for the first time.
4/20 Spending: The Per-Store Peak Is Behind Us
Eight years of transaction data from Cova's POS platform across 2,000+ dispensaries tells a clear story about where 4/20 is heading. The holiday is not fading — total industry spending on 4/20 keeps growing — but the per-store windfall that defined the early years of legalization has been permanently diluted by market saturation.
Per-store 4/20 averages from Cova's platform (2019-2026):
- 2019 (Saturday, first post-legalization 420 in Canada): $15,800 avg per store, 303 transactions (Cova, North American combined)
- 2020 (Monday, COVID lockdowns): $8,000 avg per store, 148 transactions; foot traffic dropped roughly 50%
- 2021 (Tuesday, restrictions easing): $8,700 avg per store; 8.4% rebound from 2020
- 2022 (Wednesday): $13,800 avg per store in the U.S.
- 2023 (Thursday): $11,500 avg per store in the U.S.; total 4/20 sales up 40% industrywide, but per-store averages declined as store count grew
- 2024 (Saturday): $10,254 avg per store in the U.S.; down 11% from 2023 despite favorable weekend placement
- 2025 (Easter Sunday): approximately $6,000 avg per store; suppressed by holiday conflict
- 2026 (Monday): $7,704 avg per store in the U.S., 140% above a typical Monday baseline (Cova)
Note: 2019-2021 figures are North American averages; 2022-2026 are U.S.-only.
Total transaction volume tells the other side of the story. Single-day 4/20 transactions across Cova's platform grew from 180,000+ across 1,200+ stores in 2021 to 282,572 across approximately 2,000 stores in 2024. The 4/17-4/20 window generated 787,000 transactions in 2025 and 833,925 in 2026, a 6% year-over-year increase. Consumer appetite for cannabis on 4/20 has not declined; what's declined is each store's share of it.
Promotional activity remains high: on 4/20 2026, 27.7% of transactions used a promotion and 50% of retailers ran discounts, versus roughly 10-11% on a normal day.
In Canada, where the market is more mature, 4/20 is no longer the peak sales day. Canada Day and Christmas have competed with or outperformed 4/20 in per-store sales since at least 2022. In 2026, the Canadian peak shifted to Friday April 17 ($6,492 avg per store), while 4/20 itself generated only a 27% lift. Christmas Eve outperformed 4/20 at $5,707 avg per store. Cannabis purchasing in a mature market becomes routine rather than event-driven.
Other U.S. cannabis holidays that delivered meaningful sales lifts in 2025: Green Wednesday (82%), Independence Day (77%), and Labour Day (73%) (Cova).
What this means for dispensaries: 4/20 is still the biggest single-day sales event in U.S. cannabis retail, but the per-store economics have shifted permanently. Operators should plan for it, but building a year-round promotional calendar is now more important than going all-in on a single peak day. For full 4/20 transaction data and promotional benchmarks, see the 420 Cannabis Retail Sales 2026 Infographic.
3. eCommerce and Payment Trends
Approximately 25% of all dispensary sales now happen online, according to Headset, and online orders consistently generate higher revenue per transaction than walk-in purchases. For dispensaries that haven't invested in eCommerce, that gap is both a problem and an opportunity.
Online order performance compared to walk-in:
- Online AOV: $68.01 vs. $50.56 for walk-in (35% higher)
- Online cart size: 3.9 items vs. 2.7 for walk-in (44% larger)
- 61% of shoppers review online menus before visiting a dispensary
Payment method data reveals an equally significant gap:
- Cash's share of dispensary transactions dropped from 65% to 59% in one year
- Digital payment AOV: $93.50 vs. $49.25 for cash (90% higher)
- Dispensaries offering debit card payments processed 59% more transactions than cash-only locations
Consumer expectations are also rising. According to Cannabis Business Times, 70% of consumers say digital tools are essential to their shopping experience, 75% want one-click reorder, 72% want the ability to pre-order online, and 67% want delivery options. Notably, 76% say budtender expertise directly influences what they buy — a reminder that digital convenience and human expertise are complements, not substitutes.
What this means for dispensaries: In 2026, online ordering is no longer optional if you want to stay competitive. Dispensaries without eCommerce capabilities are consistently generating lower AOV than their competitors. Reducing cash dependency has a similar effect: every payment method shift toward digital increases average transaction value. Cova's eCommerce integration and Cova Pay are built to close both gaps simultaneously.
4. Price Compression and Wholesale Trends
National wholesale flower prices averaged approximately $1,020 per pound through mid-2025, down about $100 from a year earlier, according to LeafLink's 2026 Wholesale Pricing Guide. The broader Cannabis Benchmarks Spot Index shows flower traded in a range of $888 to $1,096 per pound across 2025, hitting a near-record low of $888 in January before partially recovering to $1,081 by May 2026.
Flower's 3.04% year-over-year decline was actually the most stable period on record for that category. Other categories fared worse:
- Cartridges: -12% YoY
- Pre-rolls: -10.3% YoY
- Concentrates: -7.5% YoY
- Flower: -5.4% YoY
- Edibles: +1.7% (effectively flat)
Source: LeafLink 2026 Wholesale Pricing Guide
The variation is stark at the state level. New Jersey wholesale flower averaged $2,298 per pound in 2025, up 5%. Oregon, on the other end of the spectrum, has an estimated 3 million pounds of unsold flower in storage, with prices falling from $3,000 per pound at the market's peak to as low as $100 per pound in some cases (OLCC / Canna Law Blog). Oregon is an extreme case, but it illustrates where oversaturated markets with uncapped license counts eventually land.
The root cause isn't complicated. Whitney Economics estimates that total cultivation capacity in many states now exceeds total demand — not just legal demand, but combined legal and illicit demand. When legal supply exceeds total consumption, prices fall until producers exit the market. That's the correction that is currently playing out.
Retail gross margins have absorbed the impact: according to Headset modeling, average retail gross margins compressed from 52.6% in 2021 to 42.7% in 2025, a 10-point decline over four years.
What this means for dispensaries: Wholesale price compression benefits retail buyers on paper, but it doesn't fully offset the retail pricing pressure operators face from illicit market competition and consumer price sensitivity. The margin math is getting harder, not easier. Operators who can increase basket size, improve inventory turnover, and reduce shrinkage are the ones who will protect margins in this environment. Cova's reporting and analytics platform surfaces the specific SKU-level data operators need to make those adjustments.
5. Regulatory and Legalization Trends
Three regulatory developments are reshaping the competitive landscape in 2026: the two-phase federal rescheduling process, the hemp-derived THC ban effective November 2026, and the first serious attempt to repeal adult-use legalization in an existing market.
Federal Rescheduling Impact
Federal rescheduling is moving, but the practical impact is split across two distinct phases with very different timelines.
Phase 1 (immediate, April 23, 2026): The DOJ and DEA immediately placed FDA-approved cannabis products and qualifying state-licensed medical marijuana in Schedule III. For medical dispensaries that qualify, this creates a pathway for 280E tax relief. According to Headset, the typical qualifying dispensary would save $268,000 annually, with high-volume operators in states like California and Illinois potentially saving up to $805,000. Industry-wide, the freed cash flow is estimated at $1.6 to $2.2 billion annually for qualifying medical operators.
Phase 2 (pending, hearing set June 29, 2026): A broader rescheduling hearing that could extend Schedule III treatment to recreational cannabis begins June 29, 2026. Until that hearing concludes and a rule is finalized, recreational operators remain at Schedule I and under 280E. Operators should not assume Phase 2 outcomes or adjust accounting practices in anticipation of relief that hasn't been granted.
Operators with qualifying medical programs should be working with their accountants now to understand how Phase 1 relief applies to their specific structure.
Hemp-Derived THC Ban
Federal legislation enacted in November 2025 fundamentally changed the competitive landscape for licensed dispensaries. The law redefined "total THC" to include all THC isomers — not just delta-9 — and imposed a limit of 0.4 mg total THC per finished package on hemp products. This effectively eliminates delta-8, delta-10, HHC, THCP, and other intoxicating cannabinoids currently sold through gas stations, convenience stores, smoke shops, and online retailers. The rule takes effect November 12, 2026.
The potential impact on licensed dispensaries is significant. A substantial portion of the competitive pressure that legal operators have faced from lower-priced, unregulated hemp-derived THC products will be legally removed. Whether that translates into consumer migration toward licensed retail depends heavily on enforcement, which remains uncertain. But the legal basis for those products disappears in November, and operators who have built their value proposition around quality, compliance, and consistency are well-positioned to capture consumers who can no longer buy intoxicating hemp products at their local gas station.
State-Level Market Volatility
Beyond federal developments, the state-level picture in 2026 is one of significant divergence. New markets like New York, Ohio, and Minnesota are in rapid buildout. Established markets like California, Michigan, and Arizona are contracting: more than 4,000 businesses surrendered their licenses in an 18-month period, according to Whitney Economics.
Several states have also taken targeted action on hemp-derived THC ahead of the federal rule: Ohio capped retail licenses and banned intoxicating hemp products at the state level. Texas replaced a 1% THC cap with a 10mg-per-serving limit. Minnesota moved medical cannabis oversight to its Office of Cannabis Management and began licensing hemp edible wholesalers.
Massachusetts: The First Test of Legalization Reversal
The most closely watched state-level development in 2026 has nothing to do with expansion. A ballot campaign in Massachusetts titled “An Act to Restore a Sensible Marijuana Policy” is advancing toward a potential November 2026 vote that would repeal the adult-use legalization initiative Massachusetts voters passed with a 54% majority in 2016. If it passes, it would shut down the state’s $1.6 billion adult-use market and affect more than 25,000 cannabis industry workers, while leaving the medical program intact.
No state that has implemented a regulated adult-use cannabis program has ever reversed course, making Massachusetts a genuine test case for the durability of voter-approved legislation. The public sentiment data is not favorable to the repeal effort: just 20% of likely voters support the measure, while 63% oppose it, according to a University of New Hampshire poll conducted in early 2026 (Cannabis Business Times).
What this means for dispensaries: Operators in contracting markets face a different set of priorities than those in expanding ones. In a contracting market, survival depends on operational efficiency, customer retention, and cost discipline. In an expanding market, speed to market and compliance infrastructure matter more. Either way, the regulatory environment is more dynamic than it has ever been — and operators running on outdated compliance workflows are exposed.
6. Global Cannabis Market Trends
European cannabis sales nearly tripled from 2023 to approximately $1.5 billion in 2025, with a forecast of $2.5 billion by 2027, representing a roughly 50% compound annual growth rate (Prohibition Partners). The Czech Republic became the latest country to legalize adult-use cannabis, with home cultivation of up to three plants and possession of up to 100 grams permitted as of January 1, 2026. Germany advanced cultivation club regulations and home-grow legalization, though commercial pilot programs have stalled. Thailand moved in the opposite direction, reclassifying cannabis flowers as a controlled herb requiring a prescription in June 2025, reversing its 2022 liberalization.
North America still accounts for up to 84% of the global legal cannabis market, but the international picture is changing. European growth in particular mirrors the early-stage expansion patterns seen in U.S. state markets during their first years of regulated sales.
For full global market data and a country-by-country breakdown, see our Cannabis Industry Statistics 2026 article.
What 2026 Really Requires of Dispensary Operators
The trends above share a common thread: the era of growth covering operational inefficiency is over. When the market was expanding 20-30% annually, a dispensary with a mediocre product mix, slow eCommerce, and limited analytics could still post strong numbers. That's no longer true.
Pre-roll and beverage growth is real, but capturing it requires the right inventory, the right staff training, and the right data to know what's selling. eCommerce's revenue advantage is measurable, but only for operators who have actually built the capability. The 280E relief coming through rescheduling will help qualifying operators, but only if their accounting and compliance documentation can support the claim. And the hemp ban will redirect consumers to licensed retail, but only to dispensaries that can offer a credible alternative.
Every trend in 2026 rewards operators who run precise, data-driven businesses. Cova's cannabis POS platform, eCommerce tools, compliance features, and reporting and analytics suite are built specifically for that operating environment. If you want to see how it works for your dispensary, talk to a Cova specialist today.